Extendicare (TSE:EXE – Free Report) had its price objective boosted by TD Securities from C$9.50 to C$10.50 in a report released on Thursday morning,BayStreet.CA reports.
Separately, Royal Bank of Canada boosted their target price on shares of Extendicare from C$8.50 to C$9.50 in a research note on Monday, August 19th.
Read Our Latest Analysis on EXE
Extendicare Trading Up 1.0 %
Extendicare (TSE:EXE – Get Free Report) last posted its quarterly earnings data on Monday, August 12th. The company reported C$0.29 earnings per share for the quarter. Extendicare had a net margin of 4.28% and a return on equity of 60.00%. The business had revenue of C$348.48 million for the quarter, compared to analysts’ expectations of C$360.20 million. Equities research analysts expect that Extendicare will post 0.6134729 EPS for the current year.
Extendicare Dividend Announcement
The business also recently announced a monthly dividend, which will be paid on Friday, November 15th. Stockholders of record on Thursday, October 31st will be paid a dividend of $0.04 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 4.75%. The ex-dividend date is Thursday, October 31st. Extendicare’s dividend payout ratio is currently 70.59%.
About Extendicare
Extendicare Inc, through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties.
Featured Stories
- Five stocks we like better than Extendicare
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Top-Performing Non-Leveraged ETFs This Year
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
- Top Stocks Investing in 5G Technology
- Freshworks Stock Soars 50% – Is This the Perfect Entry Point?
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.